Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$7.44 USD
+0.11 (1.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.43 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Tango Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -101.74 | -108.18 | -58.24 | -0.12 | NA |
Depreciation/Amortization & Depletion | -0.98 | 1.61 | 0.90 | 0.00 | NA |
Net Change from Assets/Liabilities | -37.97 | -18.49 | -11.35 | -0.14 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 22.71 | 15.98 | 9.16 | -0.07 | NA |
Net Cash From Operating Activities | -117.98 | -109.08 | -59.53 | -0.33 | NA |
Property & Equipment | -1.53 | -7.69 | -1.84 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 42.95 | 34.09 | -181.60 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -166.75 | NA |
Net Cash from Investing Activities | 41.43 | 26.40 | -183.43 | -166.75 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 81.96 | 1.62 | 31.05 | 166.78 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -0.13 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.45 | -0.01 | 326.28 | 1.74 | NA |
Net Cash from Financing Activities | 82.41 | 1.62 | 357.33 | 168.39 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 5.85 | -81.07 | 114.36 | 1.31 | NA |
Cash at Beginning of Period | 63.96 | 145.02 | 30.66 | 0.00 | NA |
Cash at End of Period | 69.81 | 63.96 | 145.02 | 1.31 | NA |
Diluted Net EPS | -1.08 | -1.23 | -0.94 | -0.04 | NA |
Fiscal Year End for Tango Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -101.74 | -70.98 | -48.72 | -28.01 |
Depreciation/Amortization & Depletion | NA | -0.98 | 0.77 | -0.58 | 0.58 |
Net Change from Assets/Liabilities | NA | -37.97 | -37.22 | -21.20 | -11.69 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 22.71 | 16.91 | 11.12 | 4.21 |
Net Cash From Operating Activities | NA | -117.98 | -90.52 | -59.38 | -34.91 |
Property & Equipment | NA | -1.53 | -1.30 | -1.28 | -0.62 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 42.95 | 8.87 | 65.52 | 32.17 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 41.43 | 7.57 | 64.24 | 31.55 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 81.96 | 81.12 | 0.66 | 0.07 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.45 | -0.18 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 82.41 | 80.94 | 0.66 | 0.07 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 5.85 | -2.00 | 5.52 | -3.28 |
Cash at Beginning of Period | NA | 63.96 | 63.96 | 63.96 | 63.96 |
Cash at End of Period | NA | 69.81 | 61.96 | 69.48 | 60.68 |
Diluted Net EPS | NA | -0.30 | -0.23 | -0.23 | -0.32 |